Searched for
CENEXI PERFORMANCE
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...- Gland Pharma shares jump 11% as Q4 profit soars 97% YoY, co announces Rs 20/share final dividendShares of Gland Pharma rallied on Monday after the company reported a 97% YoY surge in Q4 profit and strong revenue growth, driven by its C...
- Gland Pharma Q2 Results: Profit rises 12% to Rs 184 croreGland Pharma on Monday reported 12 per cent year-on-year increase in profit after tax (PAT) at Rs 184 crore for the September quarter, aide...
- Gland Pharma shares rally 6% as brokerages lift ratings, target prices; here's whyGland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi....
- Gland Pharma shares in focus after subsidiary Cenexi gets 11 observations from French regulatorGland Pharma shares will be in focus after its subsidiary Cenexi received 11 observations from France’s ANSM following a GMP inspection at ...
- Gland Pharma shares zoom 12% post Q2 results; Kotak upgrades on limited downsideGland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to 'Reduce' with ...
- Gland Pharma Q4 Results: Net profit more than doubles to Rs 192.4 croreThe company declared its first-ever post-listing dividend of Rs 20 per equity share for FY24.
- Hot Stocks: Brokerage views on Gland Pharma, Bharat Forge, M&M and CG ConsumerMorgan Stanley maintained an Equal Weight rating on Crompton Greaves Consumer and an overweight rating on Bharat Forge. Jefferies recommend...
- Gland Pharma shares climb over 6% post Q2 results. Should you buy or sell?Meanwhile, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 320.5 crore, up from Rs 297 ...
- Gland Pharma shares hit 20% lower circuit after disappointing Q4 resultsGland Pharma's stock prices hit a 20% lower circuit on BSE after the firm reported a 72% YoY drop in net profit to Rs 79 crore in Q4FY23 du...
- Adani Group firms dominate list of top wealth creators in 2022; Paytm, Zomato bleed mostFrom being the country’s biggest IPO, Paytm ended up being the biggest wealth destroyer over the past year. Amidst net losses, investors ha...
Load More
